baber/WOPTO huggingface dataset:
Patent NZ-531221-A (NZ)
Title: System and method for real-time observation assessment
Inventor: BERGER LAWRENCE
IPC: G09B19/00
Filed: 2002-07-18
Abstract: A system, method and computer program product for real-time observation assessment is provided. The invention, designed for educators, takes advantage of handheld computers, desktop/laptop computers and the increasing presence of Internet access in order to reduce the paperwork associated with conventional educational assessments. The invention includes an array of instructional assessment applications designed to run on handheld computers. The instructional assessment applications may be based on existing and widely-used paper methodologies. A common Web-based platform for assessment application distribution, selection, download, data management and reporting is also provided. Users can then periodically synchronize instructional data (assessments, diagnostic results, notes and/or schedules) to the Web site. At the Web site, browser-based reports and analysis can be viewed, administered and shared via electronic mail.
Patent NZ-533871-A (NZ)
Title: Modular shade and/or rain cover system for baby vehicles
Inventor: RIVE DEBORAH ROSE
Filed: 2004-07-02
Abstract: The disclosed system has a canopy viewing panel defined between the legs of a U-shaped apron. Either a shade cover or a rain cover can be attached by zip attachment.
Patent NZ-534945-A (NZ)
Title: Data visualisation system and method
Inventor: BEARD TOM
IPC: G06F17/30
Filed: 2002-02-27
Abstract: A data visualisation system comprises: a plurality of interaction data values maintained in computer memory representing interactions between customers and merchants; a plurality of target value values maintained in computer memory corresponding to respective interaction data values; a retrieval device configured to retrieve from computer memory at least some of the data representing interactions between customers and merchants; a data constructor configured to construct a set of discrete data values from the retrieved data; an aggregator configured to construct a set of summary data values from two or more of the discrete data values and a display configured to display a representation of the discrete data values and a representation of the summary data values. The set of discrete data values constructed by the data constructor include differential data values representing the difference between respective interaction data values and corresponding target values.
Patent NZ-537582-A (NZ)
Title: Security device for a bottle
Inventor: DURBIN PAUL FRANCIS
IPC: E05B73/00
Filed: 2005-01-10
Abstract: A security device for tagging a bottle has a body defining a sleeve into which part of the bottle neck and its closure are received. A housing is defined to one side of the sleeve and first and second catch members are pivoted within the housing for movement between free and locking positions. When in their locking positions, the catch members project into the sleeve to engage behind a shoulder on the bottle neck or the closure, to resist removal of the device. An operating member is also pivoted to the housing for movement between open and closed positions, springs being arranged between the operating member and the first and second catch members to urge the catch members to their respective locking positions. A magnetically-releasable latch is arranged to hold the operating member in its closed position unless the latch member is acted upon by an external magnetic field.
Patent NZ-539727-A (NZ)
Title: Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
Inventor: BURNS CHRISTOPHER J
IPC: A61P31/12
Filed: 2003-10-31
Abstract: Disclosed is a compound of formula I in which: - R1 represents a radical selected from the group consisting of hydrogen, alkyl, halogen, and cyano; - R2 represents a radical selected from the group consisting of hydrogen, a substituted or unsubstituted alkyl radical, a substituted or unsubstituted alkoxy group, hydroxyl, cycloalkyl, cycloalkyloxy, polyfluoroalkyl, polyfluoroalkoxy, halogen, amino, monoalkylamino, dialkylamino,cyano and a substituted or unsubstituted benzyloxy group; - R3 represents a radical selected from the group consisting of hydrogen, a substituted or unsubstituted alkyl radical, a substituted or unsubstituted alkoxy group, alkenyl, halogen, hydroxy, polyfluoroalkyl, polyfluoroalkoxy, formyl, carboxyl, alkylcarbonyl, alkoxycarbonyl, hydroxyalkylcarbonyl, amino, a substituted or unsubstituted monoalkylamino, dialkylamino, cyano, amido, alkoxyamido, acetylsulfonylamino, ureido, carboxamide, sulphonamide, a substituted sulphonamide, akylthio, alkylsulfinyl, alkylsulfonyl, alkylsulfonic acid, and -O(CH2)-C(=O)-R7; - R4 represents a radical selected from the group consisting of hydrogen, alkyl, halogen, and alkoxy; - R5 represents a radical selected from the group consisting of an alkyl (C1-C6) group, cycloalkyl, and cycloalkylalkyl; - R6 substituted or unsubstituted aryl group; And the remaining substituents are as described in the specification. Also disclosed is the use of the compound in the manufacture of a medicament for prophylaxis or treatment of hepatitis C infections and diseases associated with such infections in a living host.
Patent NZ-541750-A (NZ)
Title: Use of an anti-nerve growth factor antibody and an NSAID for the preparation of a medicament for treating pain
Inventor: SHELTON DAVID L
IPC: C07K16/22
Filed: 2004-02-19
Abstract: Disclosed is the use of an anti-nerve growth factor (NGF) antibody and an amount of a non-steroidal anti-inflammatory drug (NSAID) in the manufacture of a medicament for treating pain. The NSAID can be selected from ibuprofen, naproxen and diclofenac, among others. Further disclosed are kits for treating pain, and methods for treating pain in non-human animals by administering the medicament.
Patent NZ-551007-A (NZ)
Title: Heat exchanger, typically for cooling aluminium reduction cell, with radiant and convective heat transfer within conduit
Inventor: TAYLOR MARK P
IPC: C21B9/10
Filed: 2005-05-16
Abstract: A heat exchanger 10 includes a conduit 12 for conveying cooling fluid relative to a furnace to be cooled. A heat transfer arrangement 62 is arranged in communication with an interior of the conduit 12, the heat transfer arrangement 62 and the conduit 12 together defining an assembly that is mountable adjacent the furnace to be cooled, convective heat exchange occurring, in use, due to movement of the cooling fluid relative to the furnace and the heat transfer arrangement 62 of the assembly and radiant heat exchange occurring between the furnace and at least part of the heat transfer arrangement 62 of the assembly.
Patent NZ-551982-A (NZ)
Title: IL-13 binding agents
Inventor: TCHISTIAKOVA LIOUDMILA
IPC: A61K39/395
Filed: 2005-06-17
Abstract: Disclosed is an antibody, or antigen binding fragment thereof, wherein the antibody, or antigen binding fragment thereof, comprises a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence that form an antigen binding site that binds to IL-13 with a KD of less than 10-7 M, and wherein the heavy chain comprises the amino acid sequence of: (i) G-(YF)-(NT)-I-K-D-T-Y-(MI)-H (SEQ ID NO:48), in CDR1, (ii) (WR)-I-D-P-(GA)-N-D-N-I-K-Y-(SD)-(PQ)-K-F-Q-G (SEQ ID NO:49), in CDR2, and (iii) SEENWYDFFDY (SEQ ID NO:17), in CDR3; and wherein the light chain immunoglobulin variable domain comprises the amino acid sequence of: (i) (RK)-S-S-Q-S-(LI)-(KV)-H-S-(ND)-G-N-(TN)-Y-L-(EDNQYAS) (SEQ ID NO:25), in CDR1, (ii) K-(LVI)-S-(NY)-(RW)-(FD)-S (SEQ ID NO:27), in CDR2, and (iii) Q-(GSA)-(ST)-(HEQ)-I-P (SEQ ID NO:28), in CDR3. Also disclosed is the use of the antibody in the manufacture of a medicament for treating an IL-13 associated disorder.
Patent NZ-554339-A (NZ)
Title: Concrete curing blanket
Inventor: MCDONALD STEPHEN F
Filed: 2005-10-06
Abstract: Disclosed is a method of curing concrete including wetting a target curing concrete surface; placing a first portion of a curing blanket on the target curing concrete surface; and placing a second portion of the curing blanket on the target curing concrete surface. The first portion and the second portion overlap, but are not otherwise connected for curing.
Patent NZ-574242-A (NZ)
Title: Ambient temperature thermal energy and constant pressure cryogenic engine
Inventor: NEGRE GUY
IPC: F01B17/02
Filed: 2007-07-17
Abstract: An engine uses a cryogenic fluid as a work gas that is used in a closed cycle, is stored in liquid phase and works in the gaseous phase and returned to a storage reservoir A in liquid phase. The work gas is vaporized A1 from the liquid phase at very low temperatures (<90K) and supplied to an inlet of a gas compression volumetric device B which compresses the gas to a work pressure (30 bar). The compressed gas from the compressor B, still at very low temperature, is heated by heat exchange with the atmosphere C to ambient temperature so that the gas volume increased proportionally to the increase in temperature is discharged into an expansion tank 19 at its work pressure. The compressed gas now at ambient temperature is let into a volumetric relief device D to create work. The volumetric relief device D includes an active expansion chamber 13 with a piston 14 to extract work to the engine crankshaft 9, and a main piston 1 in cylinder 2 to extract work to the engine crankshaft from the gas expanding out of cylinder 13.The gas is then exhausted from the volumetric relief device to at very low temperature (<90K) due to the expansion, and the gas is discharged toward the storage tank where it is liquefied E and stored for use in the next cycle of the engine.
Patent NZ-582250-A (NZ)
Title: Anti CD20 antibody formulations
Inventor: LASHMAR ULLA TOVE
IPC: A61K39/395
Filed: 2008-07-03
Abstract: Disclosed is an anti-CD20 antibody formulation comprising a therapeutically effective amount of an antiCD20 antibody, wherein the formulation further comprises 10 to 100 mM sodium acetate, 25 to 100 mM sodium chloride, 0.5 to 5% w/v (weight/volume) arginine free base, 0.02 to 0.2 mM EDT A, 0.01 to 0.2 % w/v polysorbate 80 and adjusted to pH 5.0 to 7.0.
Patent NZ-585858-A (NZ)
Title: Diagnostic markers of wound infection comprising measurement of procalcitonin or N-ProCT
Inventor: PERCIVAL STEVEN LANE
IPC: C07K14/585
Filed: 2008-11-20
Abstract: Disclosed is an in vitro method of diagnosis or prediction of infection of a mammalian wound, said method comprising the step of detecting the presence of a cytokine selected from the group comprising pro calcitonin and amino pro calcitonin (N-ProCT) in a sample of fluid that has been taken from the wound. Further disclosed is the use of a diagnostic device in diagnosis or prediction of infection of a mammalian wound by measuring in vitro the level of a cytokine selected from the group comprising pro calcitonin and amino pro calcitonin (N-ProCT) in a sample of fluid that has been taken from the wound, wherein the device comprises a binding partner for the cytokine.
Patent NZ-586391-A (NZ)
Title: Arrangement for achieving a representative milk sample with stirring time determined from milk yield
Inventor: GUDMUNDSSON MATS
IPC: B01F25/50
Filed: 2009-01-27
Abstract: An arrangement and method of providing a representative milk sample from an animal is disclosed. An automated milking station (1) is used including a milk extracting means (2), a milk receiver (3) and a stirring means (9, 10). The method comprises the steps of extracting the milk from the animal, transferring the milk to the receiver (3), determining the milk yield of the animal and transferring a sample from the receiver (3) to a sample unit (21). The milk is stirred before the sample is transferred to the sample unit and the stirring time is limited based on the milk yield of the animal.
Patent NZ-587157-A (NZ)
Title: Benzodiazepine compound and pharmaceutical composition
Inventor: OSHIMA KUNIO
IPC: C07D401/14
Filed: 2009-02-20
Abstract: Disclosed are benzodiazepine compounds of formula (1) or a salt thereof, wherein the substituents are as described within the specification. Examples of compounds of formula (1) include: 1-ethyl-3,3,5-trimethyl-7-{ 3-[(2-pyridin-3-ylethyl)pyridin-4-ylmethylamino]propoxy} -1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione trihydrochloride; and N-[3-(1-ethyl-3,3,5-trimethyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-7-yloxy)propyl]-N-[2-(1-oxo-1H-isoquinolin-2-yl)ethyl]benzenesulfonamide. Further disclosed is a pharmaceutical composition comprising benzodiazepine compound of formula (1) for preventing and/or treating arrhythmia, and the use of a benzodiazepine comound of formula (1) for the production of a pharmaceutical composition.
Patent NZ-587465-A (NZ)
Title: Solid composition comprising amorphous anthranilamide for pest control
Inventor: MORITA MASAYUKI
IPC: A01N43/56
Filed: 2009-03-18
Abstract: Disclosed is a solid composition for pest control which comprises an amorphous anthranilamide compound or its salt as a pesticidal active ingredient, a surfactant and a carrier.
Patent NZ-590057-A (NZ)
Title: Compositions and methods of use for therapeutic antibodies that bind a BAFFR polypeptide
Inventor: HEUSSER CHRISTOPH
IPC: A61K39/395
Filed: 2009-07-15
Abstract: Disclosed are antibodies that specifically bind to the BAFF receptor (BAFFR). More specifically antibodies that are BAFFR antagonists with in vivo B cell depleting activity and compositions and methods of use for said antibodies to treat pathological disorders that can be treated by killing or depleting B cells, such as systemic lupus erythematosus or rheumatoid arthritis or other autoimmune diseases or lymphomas, leukemias and myelomas.
Patent NZ-590914-A (NZ)
Title: Triazole antifungal agents
Inventor: GREENLEE MARK L
IPC: A01N37/18
Filed: 2009-08-07
Abstract: Disclosed are triazole compounds represented by general formula (I) or pharmaceutically acceptable salts thereof. An example of a compound of formula (I) is (1S,4aR,6aS,7R,8R,10aR,10bR,12aR,14R,15R)-15-[[(2R)-2-amino-2,3-dimethylbutyl]oxy]-8-[(1R)-1,2-dimethylpropyl]-14-[5-[[(1-methylethyl)amino]carbonyl]-1H-1,,2,4-triazol-1-yl]-1,6,6a,7,8,9,10,10a,10b,11,12,12a-dodecahydro-1,6a,8,10a-tetramethyl-4H-1,4a-propano-2H-phenanthro[ 1,2-c ]pyran-7 -carboxylic acid. Also disclosed is the use of the compounds of formula (I) for treating a fungal infection.
Patent NZ-591808-A (NZ)
Title: Synthesis of C6+ alkanes from saccharides utilising multistage catalytic processes
Inventor: CORTRIGHT RANDY D
IPC: C10G29/20
Filed: 2009-08-27
Abstract: Disclosed is a method of making C6+ paraffins / alkanes comprising: a) catalytically reacting hydrogen, water and water soluble oxygenated hydrocarbons comprising C2+O2+ hydrocarbons (such as a sugar alcohol, sugar, monosaccharide, disaccharide, alditol, cellulosic derivative, lignocellulosic derivative, glucose, fructose, sucrose, maltose etc. or mixtures thereof) in the presence of a deoxygenation catalyst at a deoxygenation temperature in the range of about 100oC to 600oC and deoxygenation pressure of at least 0.1 atmosphere to produce an oxygenate comprising C2+O1-3 hydrocarbons, wherein at least one of the C2+O1-3 hydrocarbons is a cyclic ether or a furan; b) catalytically reacting the C2+O1-3 hydrocarbons in the presence of a dehydration catalyst at a dehydration temperature of 100oC to 500oC and dehydration pressure of 0 psig to 900 psig to produce a reaction stream comprising C2+ olefins and which may also comprise one or more C4+ normal paraffins, aromatics and/or naphthenes; and c) reacting the C2+ olefins with a stream of biomass derived C4+ isoparaffins in the presence of an alkylation catalyst at an alkylation temperature in the range of about -20oC to 300oC and alkylation pressure of about 0 psig to 1200 psig to produce a product stream comprising C6+ paraffins; and wherein said process may also comprise the step of deriving said C4+ isoparaffins by catalytically reacting C4+ normal paraffins, aromatics and/or naphthenes in the presence of an isomerization catalyst to produce a stream of C4+ isoparaffins.
Patent NZ-600151-A (NZ)
Title: A process for production of a paper or paperboard product
Inventor: AXRUP LARS
IPC: D21H11/18
Filed: 2010-11-30
Abstract: 600151 Disclosed herein is a process for producing a paper or paperboard product which process comprises the steps of, providing a furnish comprising fibers, adding starch to the furnish, adding microfibrillated cellulose to the furnish, conducting the furnish to a wire in order to form a web, wherein the starch and microfibrillated cellulose is added separately to the furnish.
Patent NZ-602782-A (NZ)
Title: Wearable automatic injection device for controlled delivery of therapeutic agents
Inventor: JANG SAMUEL M
IPC: A61M37/00
Filed: 2011-04-21
Abstract: A wearable injection device (100) for subcutaneously injecting a therapeutic agent (108) into a patient 100 without using electrical power comprises a housing (102); an injection assembly; a vessel; a plunger; a plunger actuation mechanism (112); a retraction trigger and a retraction mechanism. The housing (102) comprises a patient contact portion which is securable to the patient. The injection assembly is movably disposed in the housing (102) holding a hypodermic injection needle (118) for insertion into the patient. The injection assembly is movable between a retracted position and extended position wherein the needle (118) protrudes outside the housing (102). The vessel is provided in the housing (102) for holding the therapeutic agent. The plunger is movably disposed in the vessel for ejecting the therapeutic agent (108) from the vessel into the injection assembly. The mechanical or hydraulic plunger actuation mechanism (112) actuates the plunger within the vessel. The retraction trigger is responsive to a change in state of the device (100) from an injection state to a post-injection state. The retraction mechanism automatically retracts the injection assembly from the extended position in the injection state to the retracted position in the post-injection state upon triggering by the retraction trigger. The post-injection state is entered either when the delivery of the dose to the patient is completed or when the device is removed from the patient prior to completion of the injection operation.
Patent NZ-607588-A (NZ)
Title: Antibodies against human TWEAK and uses thereof
Inventor: BAEHNER MONIKA
IPC: C07K16/24
Filed: 2012-12-24
Abstract: Discloses an antibody that binds to human TWEAK comprising 
CDR H1: GFDGSTY 
CDR H2: YVRQGT 
CDR H3: GGYNYDDAFVI 
CDR L1: QASQNIYSNLA 
CDR L2: TASYLAS 
CDR L3: QTAYYNSRPDTVA 
And the use of said antibody in the treatment of colon, lung or pancreatic cancer.
Patent NZ-613224-A (NZ)
Title: A process for the production of (meth)acrylic acid and derivatives and polymers produced therefrom
Inventor: JOHNSON DAVID WILLIAM
IPC: C07C51/48
Filed: 2012-02-08
Abstract: A method of extracting (meth)acrylic acid from an aqueous reaction medium into an organic phase in contact therewith is described. The aqueous reaction medium is formed from at least one base catalyst and at least one dicarboxylic acid selected from maleic, fumaric, malic, itaconic, citraconic, mesaconic, and citramalic acid or mixtures thereof in aqueous solution and contains the base catalysed decarboxylation products of the base catalysed reaction. The method includes either the addition of at least one of the said dicarboxylic acids and/or a pre-cursor thereof to the aqueous reaction medium to enhance the solvent extraction of the (meth)acrylic acid into the organic solvent or maintaining the level of base catalyst to dicarboxylic acid and/or pre-cursor at a sub-stoichiometric level during the extraction process. The method extends to a process of producing (meth)acrylic acid, its esters and polymers and copolymers thereof.
Patent NZ-618241-A (NZ)
Title: Method to improve process stabilization
Inventor: PUTNAM GEOFFREY H
IPC: B23K9/09
Filed: 2012-05-25
Abstract: Systems and methods for providing a start in a welding process are disclosed. The system includes a power circuit and a control circuit. The power circuit generates welding output power for a welding process. The control circuit controls the start of the welding process by generating a current pulse (440). The magnitude of the current pulse and the period of time for applying the current pulse depend on a selected run-in setting.
Patent NZ-624596-A (NZ)
Title: Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use
Inventor: BUNGARD CHRISTOPHER JAMES
IPC: C07D215/48
Filed: 2012-10-26
Abstract: Disclosed are quinoline carboxamide and quinoline carbonitrile compounds of formula (I) wherein ring A, RQ, -L-, R1, n, R2, and R3 are as defined in the specification. The compounds are useful as non-competitive metabotropic glutamate receptor 2 (mGluR2) antagonists, or mGluR2 negative allosteric modulators (NAMs), and in methods of treating diseases or disorders in which the mGluR2-NAM receptor is involved, such as Alzheimer’s disease, cognitive impairment, schizophrenia and other mood disorders, pain disorders and sleep disorders. Examples of a compound of formula (I) are: 4-(4-fluorophenyl)-7-((3-methyl-2,5-dioxoimidazolidin-1-yl)methyl)quinoline-2-carboxamide 7-[(2,5-dioxopyrrolidin-1-yl)methyl]-4-(4-methoxyphenyl)quinoline-2-carboxamide Ethyl-1-{ [2-carbamoyl-4-(4-fluorophenyl)quinolin-7-yl]methyl} -3-(trifluoromethyl)-1H-pyrazole-4-carboxylate 7-[(4,4-dimethyl-2,6-dioxopiperidin-1-yl)methyl]-4-(4-fluorophenyl)quinoline-2-carbonitrile
Patent NZ-625518-A (NZ)
Title: Eye drop composition
Inventor: AUWERX JOERI
IPC: A61P31/22
Filed: 2012-01-20
Abstract: Disclosed herein is a composition comprising at least 0.1% w/v 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-1,9-dihydro-6H-Purin-6-one (A-5021) as depicted in formula I; and at least 20% w/v of a cyclodextrin. Also disclosed is the use thereof as an ophthalmic solution for the diagnosis and treatment of herpetic eye infections in companion animals.
Patent NZ-628396-A (NZ)
Title: A roof ventilation system and a method of its use
Inventor: TIMOTHY PAUL DORRINGTON
IPC: F24F13/22
Filed: 2013-05-09
Abstract: Disclosed is a passive ventilation system for the roof of a building. It consists of a sheet of material to which blocks have been secured. The blocks include preformed channels or vents. The sheet is fitted to the ridge line of the building with which the invention is to be used. When fitted, it allows air movement in and out of the roof space via the channels in the blocks. This can reduce the formation of condensation as the roof space cools overnight which in turn reduces the potential for growth of mould in the interior of the building. The system includes a rectangular sheet of planar material, wherein the sheet has an upper surface and a lower surface, and a plurality of blocks secured to the lower surface of the sheet, the blocks running along the longitudinal length of the sheet, and wherein the blocks include a plurality of channels running substantially perpendicular to the longitudinal length of the sheet, characterised in that the sheet has a predefined line of weakness running its longitudinal length.
Patent NZ-628913-A (NZ)
Title: Segmented, semicrystalline poly(lactide-co-epsilon-caprolactone) absorbable copolymers
Inventor: ANDJELIC SASA
IPC: C08G63/08
Filed: 2013-03-01
Abstract: Novel semi-crystalline, segmented copolymers of lactide and epsilon-caprolactone exhibiting long term absorption characteristics are disclosed. The novel polymer compositions are useful for long term absorbable meshes, surgical sutures, especially monofilament sutures, and other medical devices.